菌状息肉腫治療の世界市場規模・現状・予測2021年-2027年

QYResearchが発行した調査報告書(QY21JNE2543)
◆英語タイトル:Global Mycosis Fungoides Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21JNE2543
◆発行会社(リサーチ会社):QYResearch
◆発行日:2021年6月(※2024年版があります。お問い合わせください。)
◆ページ数:99
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査資料では、菌状息肉腫治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(ステロイド外用薬、メクロレタミンゲル、HDAC阻害剤、モノクローナル抗体、局所放射線療法、体外循環光療法、その他)、用途別市場規模(病院、外来手術センター、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・菌状息肉腫治療の市場動向
・企業の競争状況、市場シェア
・菌状息肉腫治療の種類別市場規模(ステロイド外用薬、メクロレタミンゲル、HDAC阻害剤、モノクローナル抗体、局所放射線療法、体外循環光療法、その他)
・菌状息肉腫治療の用途別市場規模(病院、外来手術センター、その他)
・菌状息肉腫治療の北米市場規模2016-2027(アメリカ、カナダ)
・菌状息肉腫治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・菌状息肉腫治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・菌状息肉腫治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・菌状息肉腫治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Astellas Pharma、Bayer AG、Dover Medical and Scientific Equipment, Ltd.、Elorac, Inc.、Kyowa Kirin, Inc.、Macopharma、Soligenix, Inc.、Varian Medical Systems、Yaupon Therapeutics)
・結論
【レポートの概要】

Mycosis fungoides is most frequently encountered in primary cutaneous lymphoma. The disease progression is slow and indolent with a challenging diagnosis in the early stage of the disease which requires accurate clinical-histopathological correlation. It is a rare disease occurs usually in adults above 50 years of age, the ratio of its occurrence in men to women is 2:1.

Market Analysis and Insights: Global Mycosis Fungoides Treatment Market
The global Mycosis Fungoides Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Mycosis Fungoides Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Mycosis Fungoides Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Mycosis Fungoides Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Mycosis Fungoides Treatment market.

Global Mycosis Fungoides Treatment Scope and Market Size
Mycosis Fungoides Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Mycosis Fungoides Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Topical Steroids
Mechlorethamine Gel
HDAC Inhibitors
Monoclonal Antibodies
Localized Radiation Therapy
Extracorporeal Photopheresis
Others

Segment by Application
Hospitals
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Astellas Pharma
Bayer AG
Dover Medical and Scientific Equipment, Ltd.
Elorac, Inc.
Kyowa Kirin, Inc.
Macopharma
Soligenix, Inc.
Varian Medical Systems
Yaupon Therapeutics

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mycosis Fungoides Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Topical Steroids
1.2.3 Mechlorethamine Gel
1.2.4 HDAC Inhibitors
1.2.5 Monoclonal Antibodies
1.2.6 Localized Radiation Therapy
1.2.7 Extracorporeal Photopheresis
1.2.8 Others
1.3 Market by Application
1.3.1 Global Mycosis Fungoides Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Mycosis Fungoides Treatment Market Perspective (2016-2027)
2.2 Mycosis Fungoides Treatment Growth Trends by Regions
2.2.1 Mycosis Fungoides Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Mycosis Fungoides Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Mycosis Fungoides Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Mycosis Fungoides Treatment Industry Dynamic
2.3.1 Mycosis Fungoides Treatment Market Trends
2.3.2 Mycosis Fungoides Treatment Market Drivers
2.3.3 Mycosis Fungoides Treatment Market Challenges
2.3.4 Mycosis Fungoides Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Mycosis Fungoides Treatment Players by Revenue
3.1.1 Global Top Mycosis Fungoides Treatment Players by Revenue (2016-2021)
3.1.2 Global Mycosis Fungoides Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Mycosis Fungoides Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mycosis Fungoides Treatment Revenue
3.4 Global Mycosis Fungoides Treatment Market Concentration Ratio
3.4.1 Global Mycosis Fungoides Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mycosis Fungoides Treatment Revenue in 2020
3.5 Mycosis Fungoides Treatment Key Players Head office and Area Served
3.6 Key Players Mycosis Fungoides Treatment Product Solution and Service
3.7 Date of Enter into Mycosis Fungoides Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Mycosis Fungoides Treatment Breakdown Data by Type
4.1 Global Mycosis Fungoides Treatment Historic Market Size by Type (2016-2021)
4.2 Global Mycosis Fungoides Treatment Forecasted Market Size by Type (2022-2027)

5 Mycosis Fungoides Treatment Breakdown Data by Application
5.1 Global Mycosis Fungoides Treatment Historic Market Size by Application (2016-2021)
5.2 Global Mycosis Fungoides Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Mycosis Fungoides Treatment Market Size (2016-2027)
6.2 North America Mycosis Fungoides Treatment Market Size by Type
6.2.1 North America Mycosis Fungoides Treatment Market Size by Type (2016-2021)
6.2.2 North America Mycosis Fungoides Treatment Market Size by Type (2022-2027)
6.2.3 North America Mycosis Fungoides Treatment Market Size by Type (2016-2027)
6.3 North America Mycosis Fungoides Treatment Market Size by Application
6.3.1 North America Mycosis Fungoides Treatment Market Size by Application (2016-2021)
6.3.2 North America Mycosis Fungoides Treatment Market Size by Application (2022-2027)
6.3.3 North America Mycosis Fungoides Treatment Market Size by Application (2016-2027)
6.4 North America Mycosis Fungoides Treatment Market Size by Country
6.4.1 North America Mycosis Fungoides Treatment Market Size by Country (2016-2021)
6.4.2 North America Mycosis Fungoides Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Mycosis Fungoides Treatment Market Size (2016-2027)
7.2 Europe Mycosis Fungoides Treatment Market Size by Type
7.2.1 Europe Mycosis Fungoides Treatment Market Size by Type (2016-2021)
7.2.2 Europe Mycosis Fungoides Treatment Market Size by Type (2022-2027)
7.2.3 Europe Mycosis Fungoides Treatment Market Size by Type (2016-2027)
7.3 Europe Mycosis Fungoides Treatment Market Size by Application
7.3.1 Europe Mycosis Fungoides Treatment Market Size by Application (2016-2021)
7.3.2 Europe Mycosis Fungoides Treatment Market Size by Application (2022-2027)
7.3.3 Europe Mycosis Fungoides Treatment Market Size by Application (2016-2027)
7.4 Europe Mycosis Fungoides Treatment Market Size by Country
7.4.1 Europe Mycosis Fungoides Treatment Market Size by Country (2016-2021)
7.4.2 Europe Mycosis Fungoides Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Mycosis Fungoides Treatment Market Size (2016-2027)
8.2 Asia-Pacific Mycosis Fungoides Treatment Market Size by Type
8.2.1 Asia-Pacific Mycosis Fungoides Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Mycosis Fungoides Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Mycosis Fungoides Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Mycosis Fungoides Treatment Market Size by Application
8.3.1 Asia-Pacific Mycosis Fungoides Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Mycosis Fungoides Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Mycosis Fungoides Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Mycosis Fungoides Treatment Market Size by Region
8.4.1 Asia-Pacific Mycosis Fungoides Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Mycosis Fungoides Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Mycosis Fungoides Treatment Market Size (2016-2027)
9.2 Latin America Mycosis Fungoides Treatment Market Size by Type
9.2.1 Latin America Mycosis Fungoides Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Mycosis Fungoides Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Mycosis Fungoides Treatment Market Size by Type (2016-2027)
9.3 Latin America Mycosis Fungoides Treatment Market Size by Application
9.3.1 Latin America Mycosis Fungoides Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Mycosis Fungoides Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Mycosis Fungoides Treatment Market Size by Application (2016-2027)
9.4 Latin America Mycosis Fungoides Treatment Market Size by Country
9.4.1 Latin America Mycosis Fungoides Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Mycosis Fungoides Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Mycosis Fungoides Treatment Market Size (2016-2027)
10.2 Middle East & Africa Mycosis Fungoides Treatment Market Size by Type
10.2.1 Middle East & Africa Mycosis Fungoides Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Mycosis Fungoides Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Mycosis Fungoides Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Mycosis Fungoides Treatment Market Size by Application
10.3.1 Middle East & Africa Mycosis Fungoides Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Mycosis Fungoides Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Mycosis Fungoides Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Mycosis Fungoides Treatment Market Size by Country
10.4.1 Middle East & Africa Mycosis Fungoides Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Mycosis Fungoides Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Astellas Pharma
11.1.1 Astellas Pharma Company Details
11.1.2 Astellas Pharma Business Overview
11.1.3 Astellas Pharma Mycosis Fungoides Treatment Introduction
11.1.4 Astellas Pharma Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.1.5 Astellas Pharma Recent Development
11.2 Bayer AG
11.2.1 Bayer AG Company Details
11.2.2 Bayer AG Business Overview
11.2.3 Bayer AG Mycosis Fungoides Treatment Introduction
11.2.4 Bayer AG Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.2.5 Bayer AG Recent Development
11.3 Dover Medical and Scientific Equipment, Ltd.
11.3.1 Dover Medical and Scientific Equipment, Ltd. Company Details
11.3.2 Dover Medical and Scientific Equipment, Ltd. Business Overview
11.3.3 Dover Medical and Scientific Equipment, Ltd. Mycosis Fungoides Treatment Introduction
11.3.4 Dover Medical and Scientific Equipment, Ltd. Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.3.5 Dover Medical and Scientific Equipment, Ltd. Recent Development
11.4 Elorac, Inc.
11.4.1 Elorac, Inc. Company Details
11.4.2 Elorac, Inc. Business Overview
11.4.3 Elorac, Inc. Mycosis Fungoides Treatment Introduction
11.4.4 Elorac, Inc. Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.4.5 Elorac, Inc. Recent Development
11.5 Kyowa Kirin, Inc.
11.5.1 Kyowa Kirin, Inc. Company Details
11.5.2 Kyowa Kirin, Inc. Business Overview
11.5.3 Kyowa Kirin, Inc. Mycosis Fungoides Treatment Introduction
11.5.4 Kyowa Kirin, Inc. Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.5.5 Kyowa Kirin, Inc. Recent Development
11.6 Macopharma
11.6.1 Macopharma Company Details
11.6.2 Macopharma Business Overview
11.6.3 Macopharma Mycosis Fungoides Treatment Introduction
11.6.4 Macopharma Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.6.5 Macopharma Recent Development
11.7 Soligenix, Inc.
11.7.1 Soligenix, Inc. Company Details
11.7.2 Soligenix, Inc. Business Overview
11.7.3 Soligenix, Inc. Mycosis Fungoides Treatment Introduction
11.7.4 Soligenix, Inc. Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.7.5 Soligenix, Inc. Recent Development
11.8 Varian Medical Systems
11.8.1 Varian Medical Systems Company Details
11.8.2 Varian Medical Systems Business Overview
11.8.3 Varian Medical Systems Mycosis Fungoides Treatment Introduction
11.8.4 Varian Medical Systems Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.8.5 Varian Medical Systems Recent Development
11.9 Yaupon Therapeutics
11.9.1 Yaupon Therapeutics Company Details
11.9.2 Yaupon Therapeutics Business Overview
11.9.3 Yaupon Therapeutics Mycosis Fungoides Treatment Introduction
11.9.4 Yaupon Therapeutics Revenue in Mycosis Fungoides Treatment Business (2016-2021)
11.9.5 Yaupon Therapeutics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

...

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ 菌状息肉腫治療の世界市場規模・現状・予測2021年-2027年(Global Mycosis Fungoides Treatment Market Size, Status and Forecast 2021-2027)]についてメールでお問い合わせはこちらでお願いします。